Atlas Trials

Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein

Clinical trial NCT05274568 · COMPLETED

Trial details

NCT number
NCT05274568
Sponsor
Invicro
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson DiseaseMultisystem AtrophyHealthy Volunteer
Start date
2022-01-31
Primary completion
2023-10-25
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.